| Literature DB >> 30290451 |
Marie-Lise Jaffrain-Rea1,2,3, Adrian F Daly4, Mariolina Angelini1, Patrick Petrossians4, Vincent Bours4, Albert Beckers4,5.
Abstract
Pituitary adenomas usually present sporadically, with a multifactorial pathogenesis including somatic mutational events in cancer-related genes. Genetic predisposition implies the presence of germline DNA alterations with a range of impacts on pituitary cell biology, translating into a variable penetrance of the disease. Genetic causes must be considered in the presence of specific clinical settings, such as familial occurrence of pituitary adenoma, with or without extrapituitary diseases, and may also be suspected in young patients (<30 years of age) with macroadenomas. We review the clinical implications of genetic predisposition, with special attention on multiple endocrine neoplasia type 1, Carney complex and familial isolated pituitary adenoma. Genetic screening in selected patients with an apparently sporadic disease is also discussed.Entities:
Keywords: AIP; Carney complex; FIPA; MEN1; McCune–Albright syndrome; aryl hydrocarbon receptor-interacting protein; familial isolated pituitary adenomas; genetic screening; hereditary neoplasia; multiple endocrine neoplasia type 1; pituitary adenoma
Year: 2011 PMID: 30290451 DOI: 10.1586/eem.10.87
Source DB: PubMed Journal: Expert Rev Endocrinol Metab ISSN: 1744-6651